Michigan Medicine 19th Annual Advanced Liver Disease and Liver Transplantation Update 2025
- Free Shipping on orders over 45$
- In stock, ready to ship
- Inventory on the way
Michigan Medicine 19th Annual Advanced Liver Disease and Liver Transplantation Update 2025
+ Include: 12 videos + 1 pdf, size: 3.62 GB+ Target Audience: hepatologists, gastroenterologists, transplant surgeons, internists
+ Information:
Date & Location: Friday, April 11, 2025, 7:30 AM – 3:00 PM EST, Sheraton Detroit Novi Hotel, Novi, MI
Target Audience
Specialties – Family Medicine, Gastroenterology, General Medicine, Hepatology, Internal Medicine, Primary Care, Surgery, Transplant Surgery
Professions – House Officer, Nurse, Nurse Practitioner, Other Healthcare Professional, Physician, Physician Assistant, Social Worker
Overview
Join this hybrid program in person or virtually. This course will provide an update on recent developments in the management of patients with advanced liver disease including recent improvements in the medical management of steatotic liver disease, alcohol use disorder and alcoholic liver disease, and hepatic complications of heart disease. In addition, updates on acute on chronic liver failure, evaluation of substance use disorders in patients with advanced liver disease, liver transplantation for patients with metastatic colorectal cancer and neuroendocrine tumors, use of marginal organs in liver transplantation, and the medical management of long-term liver transplant recipients will be provided.
Objectives
At the conclusion of this activity, learners will be able to:
- implement newer approaches to the diagnosis, staging, and treatment of patients with metabolic associated liver disease
- use appropriate diagnostic tools and treatment strategies for patients with alcoholic liver disease
- understand and recognize common hepatic manifestations of patients with congenital and acquired heart disease
- understand current classification schemes and medical recommendations for patients with acute on chronic liver failure
- implement how to evaluate and treat patients with substance use disorders with underlying liver disease
- understand new data on the indications and outcomes with liver transplantation for patients with metastatic colorectal cancer and neuroendocrine tumors to the liver
- understand what is considered a “marginal organ” for liver transplantation and how they fare in adult recipients
- implement medications and treatments that are recommended for LT recipients with hyperlipidemia, cancer and metabolic bone disease
+ Topics:
- Agenda.pdf
- Acute on Chronic Liver Failure.mp4
- Detection and Management of ALD in the Outpatient Setting.mp4
- Interactive Case 1 A Transplant Candidate with AUD.mp4
- Management of Hyperlipidemia, Cancer, and Osteoporosis Post Liver Transplant.mp4
- Medical Treatments for Steatotic Liver Disease.mp4
- Panel Questions & Answers 1.mp4
- Panel Questions & Answers 2.mp4
- Panel Questions & Answers 3.mp4
- Substance Use Disorders in Advanced Liver Disease Patients.mp4
- The Heart – Liver Connection.mp4
- Transplantation for Metastatic Colorectal Cancer and Neuroendocrine Tumors.mp4
- Use of Marginal Organs in Liver Transplantation.mp4
- Orders under 45$ will have a shipping charge of a flat rate of 15$.
-Orders over 45$ will have Free Shipping.